Neurotherapeutics company MindMaze Therapeutics has announced it has raised CHF 8 million (€8.7 million) in strategic equity financing. The financing has been raised through a definitive agreement with Neuro.io, which will acquire a strategic equity position in the company. MindMaze Therapeutics says it will use the funds raised to support… Read More
AecorBio has successfully completed an equity financing round of $1.5m (£1.1m), enabling the company to investigate its lead peptide candidate FT-002a to treat advanced prostate cancer. AecorBio, formerly known as HBC Immunology Inc, will use the financing to enable an Investigational New Drug (IND) application with the US Food and… Read More
After a disappointing start to the year, the last few months have seen a boost to fundraising for UK biotech companies. DDW’s Diana Spencer unpacks the Q3 figures and annual predictions from the BioIndustry Association1. While 2021 was the highest year on record for investments into UK biotech and life… Read More
